Bluebird-JPM-2024.pdf

1、bluebird bio January 2024NASDAQ:BLUECONFIDENTIALforward-looking statements2These slides and the accompanying oral presentation contain forward-looking statements and information.The use of words such as“may,”“might,”“will,”“should,”“expect,”“plan,”“anticipate,”“believe,”“estimate,”“project,”“intend,

2、”“future,”“potential,”or“continue,”and other similar expressions are intended to identify forward-looking statements.For example,all statements we make regarding our expectations regarding our programs and therapies,including but not limited to the timing or likelihood of regulatory filings and appr

3、ovals;our manufacturing and commercialization plans,including without limitation,patient demand for our therapies,our ability to establish commercial infrastructure to support timely,equitable access to our therapies,our ability to successfully partner with payers and CMMI,our expectations on timing

4、 for activating QTCs,and our expectations on the timing and size of our QTC network and the timing of our therapies availability at our QTCs;addressable market for our therapies;our preliminary unaudited cash position as of December 31,2023;and our cash runway are forward looking.All forward-looking

5、 statements are based on estimates and assumptions by our management that,although we believe to be reasonable,are inherently uncertain.All forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those that we expected.These statement

6、s are also subject to a number of material risks and uncertainties that are described in our most recent quarterly report on Form 10-Q,as well as our subsequent filings with the Securities and Exchange Commission.Any forward-looking statement speaks only as of the date on which it was made.We undert